Gynica's mission is to provide solutions for unmet needs in women's health, with the goal of improving the quality of life for hundreds of millions of women worldwide, currently focused on developing safe, effective, nonhormonal, intravaginal drugs for endometriosis.

Gynica is owned by Asana Bio Group, a holding company specializing in scientific and technological advancements.